Sign Up to like & get
recommendations!
1
Published in 2022 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.13898
Abstract: Controversies on sub‐populations most sensitive to therapy and the best timing of starting the treatment still surround the use of immunomodulatory drugs in COVID‐19.
read more here.
Keywords:
open randomised;
early administration;
covid pneumonitis;
pneumonitis open ... See more keywords